Deborah D. Murphy
University of Virginia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Deborah D. Murphy.
American Journal of Respiratory and Critical Care Medicine | 2014
Joshua L. Kennedy; Marcus Shaker; Victoria McMeen; James E. Gern; Holliday T. Carper; Deborah D. Murphy; Wai-Ming Lee; Yury A. Bochkov; Rose F. Vrtis; Thomas A.E. Platts-Mills; James T. Patrie; Larry Borish; John W. Steinke; William A. Woods; Peter W. Heymann
RATIONALE Most virus-induced attacks of asthma are caused by rhinoviruses (RVs). OBJECTIVES To determine whether people with asthma are susceptible to an increased viral load during RV infection. METHODS Seventy-four children (4-18 yr old) were enrolled; 28 with wheezing, 32 with acute rhinitis, and 14 without respiratory tract symptoms. Nasal washes were evaluated using quantitative polymerase chain reaction for RV to judge viral load along with gene sequencing to identify strains of RV. Soluble intercellular adhesion molecule-1, IFN-λ1, and eosinophil cationic protein in nasal washes, along with blood eosinophil counts and total and allergen-specific IgE in sera, were also evaluated. Similar assessments were done in 24 young adults (16 with asthma, 8 without) who participated in an experimental challenge with RV (serotype 16). MEASUREMENTS AND MAIN RESULTS Fifty-seven percent of wheezing children and 56% with acute rhinitis had nasal washes testing positive for RV. The geometric mean of viral loads by quantitative polymerase chain reaction in washes from wheezing children was 2.8-fold lower, but did not differ significantly from children with rhinitis (7,718 and 21,612 copies of viral RNA per microliter nasal wash, respectively; P = 0.48). The odds for wheezing were increased if children who tested positive for RV were sensitized to one or more allergens (odds ratio, 3.9; P = 0.02). Similarly, neither peak nor cumulative viral loads differed significantly in washes from adults with asthma compared with those without asthma during the experimental RV challenge. CONCLUSIONS During acute symptoms, children infected with RV enrolled for wheezing or acute rhinitis had similar viral loads in their nasal washes, as did adults with and without asthma infected with RV-16 experimentally.
PLOS ONE | 2017
Peter W. Heymann; Huyen-Tran Nguyen; John W. Steinke; Ronald B. Turner; Judith A. Woodfolk; Thomas A.E. Platts-Mills; Lisa J. Martin; Hua He; Jocelyn M. Biagini Myers; Mark Lindsey; Umasundari Sivaprasad; Mario Medvedovic; Naim Mahi; Holliday T. Carper; Deborah D. Murphy; James T. Patrie; Gurjit K. Khurana Hershey
Background Rhinovirus (HRV) is associated with the large majority of virus-induced asthma exacerbations in children and young adults, but the mechanisms remain poorly defined. Methods Asthmatics and non-asthmatic controls were inoculated with HRV-A16, and nasal epithelial samples were obtained 7 days before, 36 hours after, and 7 days after viral inoculation. RNA was extracted and subjected to RNA-seq analysis. Results At baseline, 57 genes were differentially expressed between asthmatics and controls, and the asthmatics had decreased expression of viral replication inhibitors and increased expression of genes involved in inflammation. At 36 hours (before the emergence of peak symptoms), 1329 genes were significantly altered from baseline in the asthmatics compared to 62 genes in the controls. At this time point, asthmatics lacked an increase in IL-10 signaling observed in the controls. At 7 days following HRV inoculation, 222 genes were significantly dysregulated in the asthmatics, whereas only 4 genes were dysregulated among controls. At this time point, the controls but not asthmatics demonstrated upregulation of SPINK5. Conclusions As judged by the magnitude and persistence of dysregulated genes, asthmatics have a substantially different host response to HRV-A16 infection compared with non-asthmatic controls. Gene expression differences illuminate biologically plausible mechanisms that contribute to a better understanding of the pathogenesis of HRV-induced asthma exacerbations.
The Journal of Allergy and Clinical Immunology | 2012
Manuel Soto-Quiros; Lydiana Avila; Thomas A.E. Platts-Mills; John F. Hunt; Dean D. Erdman; Holliday T. Carper; Deborah D. Murphy; Silvia Odio; Hayley R. James; James T. Patrie; William Hunt; Ashli O'Rourke; Michael D. Davis; John W. Steinke; Xiaoyan Lu; Joshua L. Kennedy; Peter W. Heymann
The Journal of Allergy and Clinical Immunology | 2008
V. McMeen; Marcus S. Shaker; James E. Gern; Holliday T. Carper; Deborah D. Murphy; Rose F. Vrtis; T.A.E. Platts-Mills; Peter W. Heymann
The Journal of Allergy and Clinical Immunology | 2012
Joshua L. Kennedy; John W. Steinke; Deborah D. Murphy; H.T. Carper; Amy Polen Stallings; T.A.E. Platts-Mills; L. Borish; Peter W. Heymann
american thoracic society international conference | 2011
Manuel Soto-Quiros; Lydia Avila; John A. Hunt; Holliday T. Carper; Deborah D. Murphy; Hayley R. James; Jonathan Posthumus; Thomas A.E. Platts-Mills; Peter W. Heymann
The Journal of Allergy and Clinical Immunology | 2010
Deborah D. Murphy; Manuel Soto-Quiros; Lydiana Avila; John F. Hunt; T.A.E. Platts-Mills; Holliday T. Carper; Silvia Odio; Ashli O'Rourke; Michael D. Davis; Peter W. Heymann
The Journal of Allergy and Clinical Immunology | 2009
A. Stallings; A.P. McLaughlin; Deborah D. Murphy; Holliday T. Carper; T.A.E. Platts-Mills; Peter W. Heymann
The Journal of Allergy and Clinical Immunology | 2018
Robert Sullivan; Evan Rajadhyaksha; Patricia Jorge; Holliday T. Carper; Deborah D. Murphy; Thomas A.E. Platts-Mills; Peter W. Heymann
The Journal of Allergy and Clinical Immunology | 2016
Evan Rajadhyaksha; Patricia P. Jorge; Holliday T. Carper; Deborah D. Murphy; Lisa J. Workman; Thomas A.E. Platts-Mills; Kate Donowitz; Peter W. Heymann